Encompass Healthは2025年第4四半期の業績予想を上回り,2026年の見通しを上げ,株価を17.5%増やしました. Encompass Health beat earnings estimates in Q4 2025 and raised 2026 guidance, boosting its stock 17.5%.

Encompass Healthは2025年第4四半期に,株当たり1.46ドルの収益を報告し,推定額を上回り,年比9.9%の収益を154億ドルの収益で報告した. Encompass Health reported fourth-quarter 2025 earnings of $1.46 per share, exceeding estimates, on $1.54 billion in revenue, a 9.9% year-over-year increase. 同社は2026年度の収益ガイドラインを5.81-6-6-10に上げ,1株あたり6.37-4億円の収益を予測した. The company raised its 2026 earnings guidance to $5.81–$6.10 per share and projected revenue of $6.37–$6.47 billion. 調整されたEBITDAと営業利益は上昇し,自由キャッシュフローは改善した. Adjusted EBITDA and operating margins rose, and free cash flow improved. 株式は,その結果の17.5%を超え,更生サービスの効力と安定した財政成長に駆り立てた. The stock surged 17.5% following the results, driven by strong performance in rehabilitation services and consistent financial growth.